CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 10 enrolled
Drug / intervention
High dose vitamin Cdrug
Likely dose
High dose vitamin C 3gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01413360
NCT01413360Phase 4Completed
CompareCT.gov

Phase 4 Study of High Dose Vitamin C in Chronic Hepatitis Patients

Seoul National University Hospital·interventional·Posted Aug 10, 2011·Updated Jul 15, 2016

In Brief

A Phase 4 clinical trial evaluating High dose vitamin C for Chronic Hepatitis and 2 related conditions. Completed, enrolled 10 participants across 1 site.

Detailed Summary

The investigators will evaluate the efficacy of high dose vitamin C in chronic hepatitis patients whose serum liver enzymes are elevated more than upper limit.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Hepatitis, Chronic Hepatitis C, Chronic Alcoholic Hepatitis
CountriesSouth Korea
Collaborators--

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 10, 2011
Enrollment StartAug 1, 2011
Primary CompletionDec 1, 2013
Study CompletionDec 1, 2014
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 14.9 years ago

Interventions

High dose vitamin Cdrug

Vitamin C, 3g per day (tid), with meal, per oral with water 100mL